Evidence map›Paper›PMID 27180246›Full record

ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2016

Streptococcus salivarius by nasal spray for recurrent otitis: how good is the evidence?

S Di Mario, V Basevi, R D'Amico, C Gagliotti, M Gangemi, F Marchetti, M L Moro, G Tamburlini

Abstract readLetter
PubMed Publisher
In one paragraph

Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Bacteriotherapy with Streptococcus salivarius 24SMB and Streptococcus oralis 89a oral spray for children with recurrent streptococcal pharyngotonsillitis: a randomized placebo-controlled clinical study.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2019
    Trial
  2. The evidence for applying Streptococcus salivarius 24SMB by nasal spray for preventing recurrent acute otitis media.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2016
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

S Di MarioDocumentation Centre on Perinatal and Reproductive Health, Regional Health Authority of Emilia-Romagna, Bologna, Italy. sdimario@regione.emilia-romagna.it.
V BaseviDocumentation Centre on Perinatal and Reproductive Health, Regional Health Authority of Emilia-Romagna, Bologna, Italy.
R D'AmicoStatistics Unit, Department of Diagnostic and Clinical Medicine and Public Health, University of Modena and Reggio Emilia, Modena, Italy.
C GagliottiRegional Health and Social Agency of Emilia-Romagna, Bologna, Italy.
M GangemiLocal Health Authority of Verona, Verona, Italy.
F MarchettiDepartment of Pediatrics Ravenna Hospital, Local Health Authority of Romagna, Romagna, Italy.
M L MoroRegional Health and Social Agency of Emilia-Romagna, Bologna, Italy.
G TamburliniCentro per la Salute del Bambino, Trieste, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Nasal SpraysStreptococcus salivariusAnti-Bacterial AgentsHumansOtitisRecurrenceTreatment OutcomeAnti-Bacterial AgentsNasal Sprays

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.